Annual FCF
-$74.78 M
+$8.57 M+10.28%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual free cash flow is -$74.78 million, with the most recent change of +$8.57 million (+10.28%) on December 31, 2023.
- During the last 3 years, EIGR annual FCF has fallen by -$11.34 million (-17.87%).
- EIGR annual FCF is now -4627.05% below its all-time high of -$1.58 million, reached on December 1, 2011.
Performance
EIGR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$13.96 M
+$599.00 K+4.12%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly free cash flow is -$13.96 million, with the most recent change of +$599.00 thousand (+4.12%) on December 31, 2023.
- Over the past year, EIGR quarterly FCF has increased by +$8.52 million (+37.90%).
- EIGR quarterly FCF is now -150.22% below its all-time high of $27.79 million, reached on December 31, 2015.
Performance
EIGR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$74.78 M
+$8.52 M+10.22%
December 31, 2023
Summary
- As of February 12, 2025, EIGR TTM free cash flow is -$74.78 million, with the most recent change of +$8.52 million (+10.22%) on December 31, 2023.
- Over the past year, EIGR TTM FCF has increased by +$8.57 million (+10.28%).
- EIGR TTM FCF is now -3917.36% below its all-time high of $1.96 million, reached on March 31, 2016.
Performance
EIGR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
EIGR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.3% | +37.9% | +10.3% |
| 3 y3 years | -17.9% | +10.9% | -17.9% |
| 5 y5 years | -74.7% | -11.6% | -16.7% |
EIGR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +37.7% | at high | +42.4% | at high | +37.7% |
| 5 y | 5-year | -17.9% | +37.7% | at high | +78.0% | -18.8% | +37.7% |
| alltime | all time | -4627.1% | +37.7% | -150.2% | +78.0% | -3917.4% | +37.7% |
Eiger BioPharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$74.78 M(-10.3%) | -$13.96 M(-4.1%) | -$74.78 M(-10.2%) |
| Sep 2023 | - | -$14.55 M(-34.0%) | -$83.30 M(-6.8%) |
| Jun 2023 | - | -$22.05 M(-9.0%) | -$89.41 M(+0.3%) |
| Mar 2023 | - | -$24.22 M(+7.8%) | -$89.11 M(+6.9%) |
| Dec 2022 | -$83.35 M(-30.6%) | -$22.47 M(+8.7%) | -$83.35 M(+7.2%) |
| Sep 2022 | - | -$20.67 M(-5.0%) | -$77.78 M(+1.8%) |
| Jun 2022 | - | -$21.75 M(+17.8%) | -$76.37 M(+1.7%) |
| Mar 2022 | - | -$18.46 M(+9.2%) | -$75.08 M(-37.5%) |
| Dec 2021 | -$120.07 M(+89.3%) | -$16.90 M(-12.3%) | -$120.07 M(+1.0%) |
| Sep 2021 | - | -$19.26 M(-5.9%) | -$118.84 M(+4.5%) |
| Jun 2021 | - | -$20.46 M(-67.8%) | -$113.70 M(+4.2%) |
| Mar 2021 | - | -$63.46 M(+305.1%) | -$109.14 M(+72.0%) |
| Dec 2020 | -$63.44 M(-1.0%) | -$15.67 M(+11.0%) | -$63.44 M(+0.5%) |
| Sep 2020 | - | -$14.12 M(-11.2%) | -$63.13 M(-0.9%) |
| Jun 2020 | - | -$15.90 M(-10.5%) | -$63.68 M(+1.1%) |
| Mar 2020 | - | -$17.76 M(+15.7%) | -$62.97 M(-1.7%) |
| Dec 2019 | -$64.09 M(+49.7%) | -$15.35 M(+4.7%) | -$64.09 M(+4.7%) |
| Sep 2019 | - | -$14.67 M(-3.4%) | -$61.24 M(+1.4%) |
| Jun 2019 | - | -$15.19 M(-19.6%) | -$60.41 M(+13.7%) |
| Mar 2019 | - | -$18.88 M(+51.0%) | -$53.12 M(+24.1%) |
| Dec 2018 | -$42.81 M | -$12.50 M(-9.6%) | -$42.81 M(+5.2%) |
| Sep 2018 | - | -$13.83 M(+75.0%) | -$40.70 M(+16.5%) |
| Jun 2018 | - | -$7.90 M(-7.8%) | -$34.93 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$8.57 M(-17.5%) | -$35.96 M(-6.4%) |
| Dec 2017 | -$38.42 M(+1.0%) | -$10.39 M(+29.0%) | -$38.42 M(-1.9%) |
| Sep 2017 | - | -$8.06 M(-9.8%) | -$39.17 M(+1.9%) |
| Jun 2017 | - | -$8.94 M(-19.0%) | -$38.44 M(-15.2%) |
| Mar 2017 | - | -$11.03 M(-1.0%) | -$45.34 M(+19.2%) |
| Dec 2016 | -$38.03 M(+314.3%) | -$11.14 M(+51.9%) | -$38.03 M(-4306.6%) |
| Sep 2016 | - | -$7.33 M(-53.7%) | $904.00 K(-174.2%) |
| Jun 2016 | - | -$15.83 M(+325.4%) | -$1.22 M(-162.2%) |
| Mar 2016 | - | -$3.72 M(-113.4%) | $1.96 M(-121.3%) |
| Dec 2015 | -$9.18 M(-69.4%) | $27.79 M(-393.9%) | -$9.18 M(-80.5%) |
| Sep 2015 | - | -$9.46 M(-25.3%) | -$47.04 M(+6.5%) |
| Jun 2015 | - | -$12.65 M(-14.8%) | -$44.19 M(+16.0%) |
| Mar 2015 | - | -$14.86 M(+47.5%) | -$38.10 M(+27.0%) |
| Dec 2014 | -$30.00 M(+84.2%) | -$10.07 M(+52.6%) | -$30.00 M(+20.9%) |
| Sep 2014 | - | -$6.60 M(+0.7%) | -$24.82 M(+11.6%) |
| Jun 2014 | - | -$6.56 M(-2.9%) | -$22.25 M(+13.6%) |
| Mar 2014 | - | -$6.76 M(+38.1%) | -$19.58 M(+20.3%) |
| Dec 2013 | -$16.28 M(+10.9%) | -$4.89 M(+21.3%) | -$16.28 M(+43.0%) |
| Sep 2013 | - | -$4.03 M(+3.5%) | -$11.39 M(+54.8%) |
| Jun 2013 | - | -$3.90 M(+12.5%) | -$7.36 M(+112.5%) |
| Mar 2013 | - | -$3.46 M | -$3.46 M |
| Dec 2012 | -$14.69 M(+828.3%) | - | - |
| Dec 2011 | -$1.58 M(-71.8%) | - | - |
| Jun 2011 | -$5.61 M | - | - |
FAQ
- What is Eiger BioPharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual FCF year-on-year change?
- What is Eiger BioPharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly FCF year-on-year change?
- What is Eiger BioPharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals TTM FCF year-on-year change?
What is Eiger BioPharmaceuticals annual free cash flow?
The current annual FCF of EIGR is -$74.78 M
What is the all time high annual FCF for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual free cash flow is -$1.58 M
What is Eiger BioPharmaceuticals annual FCF year-on-year change?
Over the past year, EIGR annual free cash flow has changed by +$8.57 M (+10.28%)
What is Eiger BioPharmaceuticals quarterly free cash flow?
The current quarterly FCF of EIGR is -$13.96 M
What is the all time high quarterly FCF for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly free cash flow is $27.79 M
What is Eiger BioPharmaceuticals quarterly FCF year-on-year change?
Over the past year, EIGR quarterly free cash flow has changed by +$8.52 M (+37.90%)
What is Eiger BioPharmaceuticals TTM free cash flow?
The current TTM FCF of EIGR is -$74.78 M
What is the all time high TTM FCF for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high TTM free cash flow is $1.96 M
What is Eiger BioPharmaceuticals TTM FCF year-on-year change?
Over the past year, EIGR TTM free cash flow has changed by +$8.57 M (+10.28%)